Cargando…
Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted
Autores principales: | Panda, Aditya K., Padhi, Sunali, Pati, Abhijit, Nayak, Tapan Kumar Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442637/ https://www.ncbi.nlm.nih.gov/pubmed/34524645 http://dx.doi.org/10.1007/s13577-021-00616-x |
Ejemplares similares
-
TLR3 (rs3775291) variant is not associated with SARS-CoV-2 infection and related mortality: a population-based correlation analysis
por: Pati, Abhijit, et al.
Publicado: (2021) -
ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population
por: Pati, Abhijit, et al.
Publicado: (2020) -
Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: An observational study
por: Padhi, Sunali, et al.
Publicado: (2020) -
Three-dimensional visualization and virtual reality simulation role in hepatic surgery: Further research warranted
por: Ahmed, Faiza, et al.
Publicado: (2022) -
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
por: Verma, Henu Kumar, et al.
Publicado: (2021)